Rosenau, France

Maria Bobadilla

This inventor holds 3 USPTO granted patents and 4 published patent applications, plus 1 CIPO patent and 5 EPO patents. Top assignees: Universität Autonoma De Barcelona, Fundación Del Sector Público Estatal Centro Nacional De Investigaciones Oncologicas Carlos III (f.s.p. Cnio), Fundación Del Sector Público Estatal Centro Nacional Dl'investigaciones Oncológicas Carlos III (f.s.p. Cnio). Active years: 2019-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Maria Bobadilla. Retrieved from https://idiyas.com/inventor/maria-bobadilla

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3 

% Patents Active = 100.0

 

 

Average Co-Inventor Count = 7.8

ph-index = 1


Company Filing History:


Years Active: 2019-2022

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Maria Bobadilla: Innovator in Telomerase Therapies

Introduction

Maria Bobadilla is a prominent inventor based in Rosenau, France. She has made significant contributions to the field of biotechnology, particularly in the development of therapies related to telomerase reverse transcriptase. With a total of 3 patents, her work focuses on addressing critical health issues associated with telomere length and myocardial infarction.

Latest Patents

Maria's latest patents include innovative therapies that utilize telomerase reverse transcriptase. One of her inventions provides compositions and methods useful for the treatment and prevention of conditions associated with short telomere length. Another significant patent addresses therapies for the treatment of conditions related to myocardial infarction, offering new hope for patients suffering from this serious condition.

Career Highlights

Throughout her career, Maria has worked with esteemed organizations such as the National Center for Oncological Research Carlos III and the Autonomous University of Barcelona. Her research has been pivotal in advancing our understanding of telomerase and its applications in medical therapies.

Collaborations

Maria has collaborated with notable colleagues, including Ivan Formentini and Maria Antonia Blasco Marhuenda. These partnerships have enriched her research and contributed to the success of her innovative projects.

Conclusion

Maria Bobadilla stands out as a leading inventor in the field of telomerase therapies. Her groundbreaking work continues to pave the way for advancements in medical treatments, showcasing her dedication to improving health outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…